Lymph node metastases of melanoma: Challenges for BRAF mutation detection

Guoli Chen, Jonathan Dudley, Li Hui Tseng, Kirstin Smith, Grzegorz T. Gurda, Christopher Gocke, James Eshleman, Ming-Tseh Lin

Research output: Contribution to journalArticle

Abstract

Detection of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations is required to predict response to BRAF or mitogen-activated protein kinase kinase 1 and 2 inhibitors in metastatic melanoma. Lymph node (LN) specimens carrying melanoma cells intermingled with abundant lymphocytes often contain low tumor cellularity. This study is aimed to examine challenges in the clinical detection of BRAF mutations in LN specimens with metastatic melanoma and to illustrate characteristic features of p.V600E and non-p.V600E mutations. In this retrospective study for quality assessment of the pyrosequencing assay, we compared characteristics of 53 LN and 135 non-LN formalin-fixed, paraffin-embedded specimens with metastatic melanoma submitted for BRAF mutation detection over a 40-month period. LN specimens showed a significantly higher incidence of p.V600E mutations than non-LN specimens (49% versus 22%, P

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalHuman Pathology
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Melanoma
Lymph Nodes
Neoplasm Metastasis
Mutation
MAP Kinase Kinase 2
MAP Kinase Kinase 1
Proto-Oncogenes
Protein-Serine-Threonine Kinases
Paraffin
Formaldehyde
Retrospective Studies
Lymphocytes
Incidence
Neoplasms

Keywords

  • BRAF
  • Lymph node
  • Melanoma
  • Mutant allele-specific imbalance
  • Tumor cellularity

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Lymph node metastases of melanoma : Challenges for BRAF mutation detection. / Chen, Guoli; Dudley, Jonathan; Tseng, Li Hui; Smith, Kirstin; Gurda, Grzegorz T.; Gocke, Christopher; Eshleman, James; Lin, Ming-Tseh.

In: Human Pathology, Vol. 46, No. 1, 01.01.2015, p. 113-119.

Research output: Contribution to journalArticle

Chen, Guoli ; Dudley, Jonathan ; Tseng, Li Hui ; Smith, Kirstin ; Gurda, Grzegorz T. ; Gocke, Christopher ; Eshleman, James ; Lin, Ming-Tseh. / Lymph node metastases of melanoma : Challenges for BRAF mutation detection. In: Human Pathology. 2015 ; Vol. 46, No. 1. pp. 113-119.
@article{251641f13e814d2692952daf60de9e91,
title = "Lymph node metastases of melanoma: Challenges for BRAF mutation detection",
abstract = "Detection of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations is required to predict response to BRAF or mitogen-activated protein kinase kinase 1 and 2 inhibitors in metastatic melanoma. Lymph node (LN) specimens carrying melanoma cells intermingled with abundant lymphocytes often contain low tumor cellularity. This study is aimed to examine challenges in the clinical detection of BRAF mutations in LN specimens with metastatic melanoma and to illustrate characteristic features of p.V600E and non-p.V600E mutations. In this retrospective study for quality assessment of the pyrosequencing assay, we compared characteristics of 53 LN and 135 non-LN formalin-fixed, paraffin-embedded specimens with metastatic melanoma submitted for BRAF mutation detection over a 40-month period. LN specimens showed a significantly higher incidence of p.V600E mutations than non-LN specimens (49{\%} versus 22{\%}, P",
keywords = "BRAF, Lymph node, Melanoma, Mutant allele-specific imbalance, Tumor cellularity",
author = "Guoli Chen and Jonathan Dudley and Tseng, {Li Hui} and Kirstin Smith and Gurda, {Grzegorz T.} and Christopher Gocke and James Eshleman and Ming-Tseh Lin",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2014.09.014",
language = "English (US)",
volume = "46",
pages = "113--119",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Lymph node metastases of melanoma

T2 - Challenges for BRAF mutation detection

AU - Chen, Guoli

AU - Dudley, Jonathan

AU - Tseng, Li Hui

AU - Smith, Kirstin

AU - Gurda, Grzegorz T.

AU - Gocke, Christopher

AU - Eshleman, James

AU - Lin, Ming-Tseh

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Detection of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations is required to predict response to BRAF or mitogen-activated protein kinase kinase 1 and 2 inhibitors in metastatic melanoma. Lymph node (LN) specimens carrying melanoma cells intermingled with abundant lymphocytes often contain low tumor cellularity. This study is aimed to examine challenges in the clinical detection of BRAF mutations in LN specimens with metastatic melanoma and to illustrate characteristic features of p.V600E and non-p.V600E mutations. In this retrospective study for quality assessment of the pyrosequencing assay, we compared characteristics of 53 LN and 135 non-LN formalin-fixed, paraffin-embedded specimens with metastatic melanoma submitted for BRAF mutation detection over a 40-month period. LN specimens showed a significantly higher incidence of p.V600E mutations than non-LN specimens (49% versus 22%, P

AB - Detection of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations is required to predict response to BRAF or mitogen-activated protein kinase kinase 1 and 2 inhibitors in metastatic melanoma. Lymph node (LN) specimens carrying melanoma cells intermingled with abundant lymphocytes often contain low tumor cellularity. This study is aimed to examine challenges in the clinical detection of BRAF mutations in LN specimens with metastatic melanoma and to illustrate characteristic features of p.V600E and non-p.V600E mutations. In this retrospective study for quality assessment of the pyrosequencing assay, we compared characteristics of 53 LN and 135 non-LN formalin-fixed, paraffin-embedded specimens with metastatic melanoma submitted for BRAF mutation detection over a 40-month period. LN specimens showed a significantly higher incidence of p.V600E mutations than non-LN specimens (49% versus 22%, P

KW - BRAF

KW - Lymph node

KW - Melanoma

KW - Mutant allele-specific imbalance

KW - Tumor cellularity

UR - http://www.scopus.com/inward/record.url?scp=84915737373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915737373&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.09.014

DO - 10.1016/j.humpath.2014.09.014

M3 - Article

C2 - 25456393

AN - SCOPUS:84915737373

VL - 46

SP - 113

EP - 119

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -